GlassScriptPhysician profile
Amir Singh
NPI 1780144899
$1,028.62
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.75 · 2023: $456 · 2024: $420 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568 · Education: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.81 |
| Education | $440.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $385.17 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $282.59 | 2023-2025 | Lifevest |
| Lantheus Medical Imaging, INC. | $90.24 | 2023-2025 | Definity |
| Boston Scientific Corporation | $54.35 | 2025 | Watchman Access System, Resonate El Icd Vr |
| Atricure, INC. | $43.91 | 2024 | |
| Irhythm Technologies, INC. | $41.18 | 2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $29.70 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $26.92 | 2024 | Endurant Iis |
| Heartflow, INC. | $26.32 | 2023 | Ffrct |
| Bayer Healthcare Pharmaceuticals INC. | $20.75 | 2022 | |
| Biosense Webster, INC. | $13.91 | 2023 | Na |
| Abiomed | $13.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.